F

Florida Urology Partners, LLP | Tampa, FL

Research site

(Unclaimed)

Location

5913 Webb Road, Tampa, Florida, United States of America

Site insights

Top conditions

Top treatments

Relugolix

Enzalutamide

177Lu-

Vibegron

Prednisone

Leuprolide Acetate

Abiraterone

Parent organization

This site is a part of Florida Urology Partners, LLP

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Met...

Active, not recruiting

Metastasis From Malignant Tumor of Prostate

Drug: 177Lu-PSMA-I&T

Drug: Abiraterone with Prednisone or Enzalutamide

ProVIDE II Bridging Study

The purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander i...

Active, not recruiting

BPH With Symptomatic Lower Urinary Tract Symptoms

Device: ProVee device

Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting

Prostate Cancer

Drug: Leuprolide Acetate

Drug: Relugolix